(Q35826466)

10 August 2017

1 reference

title

The emerging role of bortezomib in the treatment of indolent non-Hodgkin's and mantle cell lymphomas (English)

1 reference

10 August 2017

Owen A O'Connor

1

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Current Treatment Options in Oncology

10 August 2017

published in

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

269-281

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-004-0018-2

10 August 2017

exact match

0 references

cites work

The ubiquitin-proteasome pathway in cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-004-0018-2

Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-004-0018-2

PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis

21 January 2018

1 reference

12 December 2020

Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids

1 reference

12 December 2020

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

12 December 2020

NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

1 reference

12 December 2020

Proteasome-dependent regulation of p21WAF1/CIP1 expression

1 reference

12 December 2020

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

1 reference

12 December 2020

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

1 reference

12 December 2020

The ubiquitin-proteasome pathway: on protein death and cell life

1 reference

12 December 2020

Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.

1 reference

12 December 2020

Proteasome inhibition: a new strategy in cancer treatment

1 reference

12 December 2020

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

1 reference

12 December 2020

Detailed analysis of cell cycle kinetics upon proteasome inhibition

1 reference

12 December 2020

Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha

1 reference

12 December 2020

NF-kappa B: ten years after

1 reference

12 December 2020

Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution

1 reference

12 December 2020

Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides

1 reference

12 December 2020

Dis-assembly lines: the proteasome and related ATPase-assisted proteases

1 reference

12 December 2020

How proteolysis drives the cell cycle

1 reference

12 December 2020

Proteasome inhibitors: valuable new tools for cell biologists

1 reference

12 December 2020

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma

1 reference

12 December 2020

Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide

1 reference

12 December 2020

NF-kappa B: a lesson in family values

1 reference

12 December 2020

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

1 reference

12 December 2020

10.1007/S11864-004-0018-2

Identifiers

DOI

1 reference

10 August 2017

1 reference